Q1 2026 Holdings
Filed 2026-05-15 | 40 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $250.6M | 2,577,333 | 19.0% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $193.1M | 3,007,164 | 14.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $143.5M | 14,418,574 | 10.9% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $113.7M | 5,957,165 | 8.6% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $81.6M | 88,783,856 | 6.2% |
| Illumina Inc(ILMN) | COM | 452327109 | $65.3M | 530,000 | 4.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $56.6M | 1,175,000 | 4.3% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $48.3M | 2,275,000 | 3.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $35.3M | 1,840,000 | 2.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $32.2M | 1,350,000 | 2.4% |
| Guardant Health Inc(GH) | COM | 40131M109 | $29.1M | 315,000 | 2.2% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $28.6M | 1,420,361 | 2.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $24.8M | 75,000 | 1.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $22.7M | 758,857 | 1.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $17.2M | 350,000 | 1.3% |
| Agomab Therapeutics NV(AGMB) | SPONSORED ADS | 00860C102 | $16.3M | 1,550,000 | 1.2% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $14.5M | 700,000 | 1.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $14.5M | 3,250,000 | 1.1% |
| Qiagen NV | ORD SHARES | N72482156 | $14.4M | 360,000 | 1.1% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $13.3M | 294,127 | 1.0% |
| Septerna Inc(SEPN) | COM | 81734D104 | $13.3M | 553,268 | 1.0% |
| Grail Inc(GRAL) | COM | 384747101 | $11.9M | 230,000 | 0.9% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $11.0M | 3,167,175 | 0.8% |
| Personalis Inc(PSNL) | COM | 71535D106 | $10.2M | 1,600,000 | 0.8% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $9.8M | 50,000 | 0.7% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $8.9M | 276,308 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $8.4M | 450,000 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $4.6M | 355,000 | 0.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.2M | 65,000 | 0.3% |
| Moderna Inc(MRNA) | COM | 60770K107 | $3.8M | 75,000 | 0.3% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $3.7M | 538,461 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.1M | 186,014 | 0.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.9M | 973,260 | 0.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $2.8M | 1,228,190 | 0.2% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $2.5M | 282,312 | 0.2% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.9M | 148,333 | 0.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $955.4K | 723,767 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $507.5K | 165,323 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $250.6K | 361,969 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $223.7K | 36,493 | 0.0% |